These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35970707)

  • 1. Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults.
    Xiong X; Dalziel K; Huang L; Rivero-Arias O
    Value Health; 2023 Jan; 26(1):50-54. PubMed ID: 35970707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.
    Dalziel K; Catchpool M; García-Lorenzo B; Gorostiza I; Norman R; Rivero-Arias O
    Pharmacoeconomics; 2020 May; 38(5):499-513. PubMed ID: 31974830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Adult and Adolescent Preferences Toward EQ-5D-Y-3L Health States.
    Prevolnik Rupel V; Ramos-Goñi JM; Ogorevc M; Kreimeier S; Ludwig K; Greiner W
    Value Health; 2021 Sep; 24(9):1350-1359. PubMed ID: 34452716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
    Mott DJ; Shah KK; Ramos-Goñi JM; Devlin NJ; Rivero-Arias O
    Med Decis Making; 2021 Jul; 41(5):584-596. PubMed ID: 33733920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
    Verstraete J; Amien R; Scott D
    Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L.
    Karim S; Craig BM; Groothuis-Oudshoorn CGM
    Health Qual Life Outcomes; 2022 May; 20(1):85. PubMed ID: 35614472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Do Adults Value EQ-5D-Y-3L Health States Differently for Themselves Than for Children and Adolescents: A Think-Aloud Study.
    Reckers-Droog V; Karimi M; Lipman S; Verstraete J
    Value Health; 2022 Jul; 25(7):1174-1184. PubMed ID: 35168891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
    Ramos-Goñi JM; Estévez-Carrillo A; Rivero-Arias O; Rowen D; Mott D; Shah K; Oppe M
    Value Health; 2022 Jul; 25(7):1196-1204. PubMed ID: 35379562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
    Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
    Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Like holding the axe on who should live or not': adolescents' and adults' perceptions of valuing children's health states using a standardised valuation protocol for the EQ-5D-Y-3L.
    Åström M; Conte H; Berg J; Burström K
    Qual Life Res; 2022 Jul; 31(7):2133-2142. PubMed ID: 35201557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value Set for the EQ-5D-Y-3L in Hungary.
    Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.
    Amien R; Scott D; Verstraete J
    Health Qual Life Outcomes; 2023 Feb; 21(1):19. PubMed ID: 36814254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Valuation Protocol for the EQ-5D-Y-3L.
    Ramos-Goñi JM; Oppe M; Stolk E; Shah K; Kreimeier S; Rivero-Arias O; Devlin N
    Pharmacoeconomics; 2020 Jul; 38(7):653-663. PubMed ID: 32297224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
    Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
    Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
    Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity.
    Shiroiwa T; Fukuda T; Shimozuma K
    Qual Life Res; 2019 Nov; 28(11):3093-3105. PubMed ID: 31243620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.